机构:[1]Institute of Clinical Pharmacology, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510403, China.深圳市中医院深圳医学信息中心[2]Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, Guangdong 511436, China.[3]Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215123, China.[4]Division of Hematology & Oncology, Department of Geriatrics, Guangzhou First People's Hospital, College of Medicine, South China University of Technology, Guangzhou, Guangdong 510180, China.
The National Natural
Science Foundation of China (No. 81770154, 81970194, and
82170176), the National Key Research and Development
Program of China (No. 2022YFC2705003), Guangzhou Medical University Discipline Construction Funds (Basic
Medicine) (China) (No. JCXKJS2022A05), and Guangzhou
Key Discipline of Medicine (Geriatric Medicine) (China) (No.
ZDXK202103).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|2 区医学
小类|2 区生化与分子生物学2 区遗传学
最新[2025]版:
大类|2 区医学
小类|2 区生化与分子生物学2 区遗传学
第一作者:
第一作者机构:[1]Institute of Clinical Pharmacology, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510403, China.[2]Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, Guangdong 511436, China.
共同第一作者:
通讯作者:
通讯机构:[1]Institute of Clinical Pharmacology, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510403, China.[2]Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, Guangdong 511436, China.[4]Division of Hematology & Oncology, Department of Geriatrics, Guangzhou First People's Hospital, College of Medicine, South China University of Technology, Guangzhou, Guangdong 510180, China.[*1]Institute of Clinical Pharmacology, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510403, China.
推荐引用方式(GB/T 7714):
Zhang Hongxia,Zhong Yueya,He Yuanming,et al.RNF6 promotes chronic myelogenous leukemia cell proliferation and migration by stabilizing vimentin via multiple atypical ubiquitinations[J].Genes & diseases.2024,11(1):87-90.doi:10.1016/j.gendis.2023.04.004.
APA:
Zhang Hongxia,Zhong Yueya,He Yuanming,Xu Yujia,Ren Ying...&Mao Xinliang.(2024).RNF6 promotes chronic myelogenous leukemia cell proliferation and migration by stabilizing vimentin via multiple atypical ubiquitinations.Genes & diseases,11,(1)
MLA:
Zhang Hongxia,et al."RNF6 promotes chronic myelogenous leukemia cell proliferation and migration by stabilizing vimentin via multiple atypical ubiquitinations".Genes & diseases 11..1(2024):87-90